(S1 (S (NP (NP (NN Brn-3a)) (, ,) (NP (NP (DT a) (JJ neuronal) (NN transcription) (NN factor)) (PP (IN of) (NP (DT the) (NN POU) (NN gene) (NN family)))) (: :) (NP (NP (NNS indications)) (PP (IN for) (NP (NP (PRP$ its) (NN involvement)) (PP (IN in) (NP (NP (NN cancer)) (CC and) (NP (NN angiogenesis))))))) (. .))))
(S1 (S (S (NP (NP (NN Brn-3a)) (, ,) (NP (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NN POU) (NN gene) (NN family)))) (PRN (-LRB- -LRB-) (NP (NP (JJ so-called)) (PP (IN because) (PP (IN of) (NP (NP (DT the) (NN similarity)) (PP (IN with) (NP (NP (DT the) (NN group)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (NP (NP (NN Pit)) (, ,) (NP (NN Oct)) (, ,) (CC and) (NP (NN Unc))))))))))) (-RRB- -RRB-))) (, ,)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (JJ neuronal) (NNS cells)) (VP (VBN engaged) (PP (IN in) (NP (NP (DT the) (NN transcription) (NN activity)) (PP (IN of) (NP (NP (NP (DT the) (NP (NN p1)) (CC and) (NP (NN p2))) (NNS promoters)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ powerful)) (JJ antiapoptotic) (NN gene)) (, ,) (ADVP (RB namely)) (, ,) (NP (NN Bcl-2)))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ alternative) (NN splicing)) (PP (IN of) (NP (NN Brn-3a) (NN mRNA)))) (VP (VBZ produces) (NP (NP (CD two) (JJ molecular) (NNS forms)) (: :) (NP (DT a) (ADVP (RBR longer)) (, ,) (NP (NN Bcl-2) (NN transactivating) (NN form)) (, ,) (CC and) (NP (DT a) (JJR shorter) (JJ inactive) (NN form)))) (, ,) (S (VP (VBG lacking) (NP (NP (CD 84) (NNS AA)) (PP (IN in) (NP (DT the) (NN aminoterminus)))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (JJ neuronal) (NNS cells))) (, ,) (PP (VBG following) (NP (NP (NN Brn-3a) (NN gene) (NN transfection)) (CC and) (NP (NN superexpression)))) (, ,) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (CD 30) (NN fold)) (PP (IN of) (NP (DT the) (NN Bcl-2) (NN protein)))))) (VP (VBZ occurs) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NN apoptosis) (NN protection))))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (JJ recent) (NNS works)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN Brn-3a) (NN expression)) (VP (VBZ is) (RB not) (ADJP (JJ restricted) (PP (TO to) (NP (JJ neuronal) (NNS cells)))) (, ,) (SBAR (IN as) (S (NP (PRP$ its) (NN activity)) (VP (VBD was) (VP (VBN detected) (ADVP (RB also)) (PP (IN in) (NP (NP (NN cancer) (NNS cells)) (PP (IN of) (NP (JJ non-neuronal) (NN nature)))))))))))))) (. .)))
(S1 (S (S (VP (VBG Looking) (PP (IN for) (NP (NP (NNS mechanisms)) (VP (VBG linking) (NP (NN Brn-3a)) (PP (TO to) (NP (NN carcinogenesis)))))))) (, ,) (NP (PRP we)) (VP (VBP discuss) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT this) (NN transcription) (NN factor))) (PP (IN in) (S (VP (VBG influencing) (NP (NP (NP (NN Bcl-2/p53) (NN antagonism)) (CC and) (NP (NN Bcl-2/VEGF) (NN induction))) (PP (IN of) (NP (NN tumor) (NN angiogenesis)))))))) (, ,) (S (VP (VBG concluding) (NP (DT this) (NN review)) (PP (IN with) (NP (NP (DT a) (NN proposal)) (PP (IN for) (NP (NP (DT the) (JJ oncogenic) (NN nature)) (PP (IN of) (NP (NN Brn-3a)))))))))) (. .)))
